How Natural Killer Cell Therapy Offers a Lifeline to COVID-19 ARDS Patients
Recent trials of the iNKT cell therapy agenT-797 have demonstrated significant improvements in survival rates for critically ill COVID-19 patients with ARDS. This innovative treatment, which bolsters the immune response and reduces inflammation, offers hope for broader applications beyond COVID-19. Credit: SciTechDaily.comInitial trial suggests invariant natural killer cell therapy improves survival.Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill…